Literature DB >> 2208576

Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.

G Nocentini1, A Barzi, P Franchetti.   

Abstract

The cytotoxicity of hydroxyurea in combination with 2.2'-bipyridyl-6-carbothioamide (a potential inhibitor of ribonucleotide reductase) on P388 murine leukemia is reported. Synergistic activity was studied using various interpretations of the isobologram method and the combination index method. We evaluated the pros and cons of these methods and their overall usefulness. In our opinion, to obtain all possible information from a compound association, it is important to choose a formally correct method that (a) can quantitatively evaluate synergism or antagonism, (b) may offer the possibility of averaging final results, (c) needs a minimal amount of experimental data, and (d) is rapid. Moreover, we emphasize both the utility of testing at least three molar ratios of compound association and the importance of carefully choosing the fractional inhibition used in calculating the combination effect. Such evaluation of drug combinations gives information essential to the preparation of new anticancer drug regimens and to the early assessment of biochemical interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208576     DOI: 10.1007/bf02897291

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  27 in total

1.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

Review 2.  The metabolic basis for combination chemotherapy.

Authors:  L E Damon; E C Cadman
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

3.  Hydroxyurea therapy in chronic myelogenous leukemia.

Authors:  B J Kennedy
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

Review 4.  Ribonucleotide reductase inhibitors as anticancer and antiviral agents.

Authors:  E J Lien
Journal:  Prog Drug Res       Date:  1987

5.  The expected effect of a combination of agents: the general solution.

Authors:  M C Berenbaum
Journal:  J Theor Biol       Date:  1985-06-07       Impact factor: 2.691

6.  Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraints.

Authors:  G L Wampler; W H Carter; V R Williams
Journal:  Cancer Treat Rep       Date:  1978-03

7.  Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.

Authors:  G G Steel; M J Peckham
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-01       Impact factor: 7.038

8.  Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Eur J Biochem       Date:  1981-03-16

9.  Synergistic effect of adriamycin and ricin on L1210 leukemic cells in mice.

Authors:  O Fodstad; A Pihl
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

10.  Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.

Authors:  T T Chang; S Gulati; T C Chou; M Colvin; B Clarkson
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

View more
  1 in total

1.  Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C).

Authors:  P B Koneru; E J Lien; V I Avramis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.